- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Comparing Treatment Options for Acute Pyelonephritis From a Meta-Analysis
An expert briefly describes the study “Evaluation of Clinical Efficacy of Systemic Antibiotics for Treatment of Acute Pyelonephritis in Adults: A Network Meta-Analysis of Randomized Controlled Trials,” including its objective, design, methodology, results, and key takeaways, and discusses how the new data impacts the management of patients with acute pyelonephritis.
EP: 1.Unmet Needs in the Management of UTIs
EP: 2.Gepotidacin vs Nitrofurantoin in uUTI: Study Overview and Clinical Implications
EP: 3.Rethinking Uncomplicated UTI Treatment: Discussion of Aminoglycosides as an Alternative to Carbapenems
EP: 4.Comparing Treatment Options for Acute Pyelonephritis From a Meta-Analysis
EP: 5.Addressing Unmet Needs and Future Outlooks in Treatment of Uncomplicated UTI
Video content above is prompted by the following:
- Briefly describe the study “Evaluation of Clinical Efficacy of Systemic Antibiotics for Treatment of Acute Pyelonephritis in Adults: A Network Meta-Analysis of Randomized Controlled Trials.”
- What was the objective of this study?
- How was this study designed/what methodology was used?
- What results were presented?
- Provide your key takeaways from this study. How does this new data impact your management of patients with acute pyelonephritis?
Politics vs Science: The Future of US Public Health
February 4th 2025On this episode of Managed Care Cast, we speak with Perry N. Halkitis, PhD, MS, MPH, dean of the Rutgers School of Public Health, on the public health implications of the US withdrawal from the World Health Organization and the role of public health leaders in advocating for science and health.
Listen
Bird Flu Risks, Myths, and Prevention Strategies: A Conversation With the NFID's Dr Robert Hopkins
January 21st 2025Joining us for this episode of Managed Care Cast is Robert H. Hopkins Jr, MD, medical director at the National Foundation for Infectious Diseases (NFID), who will help separate fact from fiction about avian influenza and discuss what needs to be done to prevent a future escalation.
Listen
The Argument Against Routine Antibiotics for Patients With Nonsevere COVID-19
May 19th 2025Over 500,000 US patients hospitalized with nonsevere COVID-19 saw no clinically significant benefit and potential harm associated with routine early antibiotic treatment, supporting antibiotic stewardship to limit unnecessary use.
Read More
